Company · CIK 1628587
Teva Pharmaceutical Finance Netherlands II B.V.
| CIK | 1628587 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | P7 |
| Business address | Netherlands |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | none on EDGAR |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-284770-03 | 2025-02-07 | 2026-09-11 | 5 | |
| 333-260519-03 | 2021-10-27 | 2023-03-03 | 4 | |
| 333-222767-01 | 2018-01-29 | 2018-01-29 | 1 |
Filings
11| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-09-11 | 424B5Shelf takedown | 333-284770-03 | 0001193125-26-389382 |
| 2026-09-09 | 424B5Shelf takedown | 333-284770-03 | 0001193125-26-386121 |
| 2025-05-22 | 424B5Shelf takedown | 333-284770-03 | 0001193125-25-125044 |
| 2025-05-19 | 424B5Shelf takedown | 333-284770-03 | 0001193125-25-122087 |
| 2025-02-07 | S-3ASRShelf registered | 333-284770-03 | 0001193125-25-022747 |
| 2023-03-03 | 424B5Shelf takedown | 333-260519-03 | 0001193125-23-058961 |
| 2023-02-27 | 424B5Shelf takedown | 333-260519-03 | 0001193125-23-049644 |
| 2021-11-04 | 424B5Shelf takedown | 333-260519-03 | 0001193125-21-320227 |
| 2021-10-27 | S-3ASRShelf registered | 333-260519-03 | 0001193125-21-308706 |
| 2020-08-17 | EFFECTDeclared effective | 333-241010-01 | 9999999995-20-002171 |
| 2018-01-29 | S-3Shelf registered | 333-222767-01 | 0001193125-18-023821 |